Storytelling to Support Disease Self-Management by Adults With Type 2 Diabetes
Overview
Authors
Affiliations
Objectives: This pilot project aimed to examine the acceptability and feasibility of a group storytelling intervention to support self-management among adults living with type 2 diabetes.
Methods: Two waves of a single-arm storytelling intervention, consisting of 8 sessions at a community health centre, were delivered to 8 adults with type 2 diabetes. Diabetes educators facilitated each session, in which patients shared stories about diabetes-self-management topics of their choice. Focus groups with both patients and facilitators explored the feasibility and acceptability of the sessions. External raters assessed the fidelity of the intervention's implementation.
Results: Overarching themes describe the acceptability and feasibility of the intervention: 1) the facilitation of patient self-direction, group cohesion, collective learning and support; 2) roles of facilitator educator, and peer learner; 3) the intervention's customization to patients' preferences. The sessions were delivered with high fidelity (averaging 84.4%).
Conclusions: Informal group storytelling enables patients to discuss, understand and give personal meaning to the information that was exchanged, and facilitates educators' better understanding of patients' concerns and gaps in knowledge and how-to strategies that can inform their practice. The group storytelling intervention is acceptable to patients and educators and can be delivered with high fidelity. Further research into effective patient recruitment methods and evaluation of the intervention's impact on diabetes self-management is required.
Process Evaluations of Diabetes Self-Management Programs: A Systematic Review of the Literature.
Nsobundu C, Nmadu Y, Wagle N, Foster M, McKyer E, Sherman L Am J Health Promot. 2024; 38(7):1048-1067.
PMID: 38648265 PMC: 11348640. DOI: 10.1177/08901171241238554.
Ali S, Bakht S, Ullah Jan A, Alam I, Almajwal A, Osaili T Front Public Health. 2023; 11:1215166.
PMID: 37869196 PMC: 10585594. DOI: 10.3389/fpubh.2023.1215166.
Nechuta S, Wallace H J Natl Cancer Inst. 2023; 115(4):345-348.
PMID: 36744916 PMC: 10086619. DOI: 10.1093/jnci/djad026.
Zarifsaniey N, Shirazi M, Mehrabi M, Bagheri Z BMC Endocr Disord. 2022; 22(1):74.
PMID: 35317771 PMC: 8941790. DOI: 10.1186/s12902-022-00988-7.
Carrier M, Beverly E Clin Diabetes. 2021; 39(2):176-187.
PMID: 33981131 PMC: 8061556. DOI: 10.2337/cd20-0082.